Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
14.33
+0.31 (2.19%)
At close: Mar 24, 2026, 4:00 PM EDT
14.32
-0.01 (-0.05%)
After-hours: Mar 24, 2026, 4:10 PM EDT
Mesoblast Employees
Mesoblast had 81 employees as of June 30, 2025. The number of employees increased by 8 or 10.96% compared to the previous year.
Employees
81
Change (1Y)
8
Growth (1Y)
10.96%
Revenue / Employee
$807,210
Profits / Employee
-$1,165,062
Market Cap
1.85B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 81 | 8 | 10.96% |
| Jun 30, 2024 | 73 | -10 | -12.05% |
| Jun 30, 2023 | 83 | 6 | 7.79% |
| Jun 30, 2022 | 77 | -6 | -7.23% |
| Jun 30, 2021 | 83 | -19 | -18.63% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Sarepta Therapeutics | 835 |
| Ascentage Pharma Group International | 605 |
| Ocular Therapeutix | 325 |
| Relay Therapeutics | 192 |
| Stoke Therapeutics | 170 |
| Aurinia Pharmaceuticals | 128 |
| Definium Therapeutics | 106 |
MESO News
- 6 days ago - Mesoblast to Host R&D Day on April 8, 2026 - GlobeNewsWire
- 12 days ago - Dr. Teresa Montagut Appointed as Clinical Development and Medical Affairs Head at Mesoblast - GlobeNewsWire
- 25 days ago - Mesoblast (MESO) Reports Significant Miss in 1H Earnings - GuruFocus
- 25 days ago - Mesoblast Limited (MESO) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 25 days ago - Half Year 2026 Mesoblast Ltd Earnings Presentation Transcript - GuruFocus
- 25 days ago - Ryoncil® Profits Underpinning Substantial Growth Pipeline - GlobeNewsWire
- 27 days ago - What's Next: Mesoblast's Earnings Preview - Benzinga
- 4 weeks ago - Mesoblast Financial Results and Corporate Update Webcast - GlobeNewsWire